Evidence map›Paper›PMID 27911941›Full record

ArticlePloS one2016

Copper Oxide Nanoparticles Impact Several Toxicological Endpoints and Cause Neurodegeneration in Caenorhabditis elegans.

Michael J Mashock, Tyler Zanon, Anthony D Kappell, Lisa N Petrella, Erik C Andersen, Krassimira R Hristova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. High-Throughput Toxicity Screening withEnvironmental science & technology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Identification of Toxicity Effects of CuEnvironmental science. Nano · 2020
    Article
  16. A circular RNARSC advances · 2019
    Article
  17. Article
  18. Impact of nanoparticles on neuron biology: current research trends.International journal of nanomedicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael J MashockDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.ORCID http://orcid.org/0000-0003-0141-9770
Tyler ZanonDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Anthony D KappellDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Lisa N PetrellaDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Erik C AndersenDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, United States of America.
Krassimira R HristovaDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Marquette University · USNorthwestern University · US

Funding

Pilot Project ProgramP30ES004184 · NIEHS · UNIVERSITY OF WISCONSIN MILWAUKEE · PI PETERING, DAVID HAROLD · 1987 to 2015
$11.8M
Determination of the distribution of fitness effects of mutations in C. elegansR01GM107227 · NIGMS · UNIVERSITY OF FLORIDA · PI BAER, CHARLES F · 2014 to 2017
$1.1M
NIEHS NIH HHS P30 ES004184NIGMS NIH HHS R01 GM107227
6 · The paper itself

Abstract

Engineered nanoparticles are becoming increasingly incorporated into technology and consumer products. In 2014, over 300 tons of copper oxide nanoparticles were manufactured in the United States. The increased production of nanoparticles raises concerns regarding the potential introduction into the environment or human exposure. Copper oxide nanoparticles commonly release copper ions into solutions, which contribute to their toxicity. We quantified the inhibitory effects of both copper oxide nanoparticles and copper sulfate on C. elegans toxicological endpoints to elucidate their biological effects. Several toxicological endpoints were analyzed in C. elegans, including nematode reproduction, feeding behavior, and average body length. We examined three wild C. elegans isolates together with the Bristol N2 laboratory strain to explore the influence of different genotypic backgrounds on the physiological response to copper challenge. All strains exhibited greater sensitivity to copper oxide nanoparticles compared to copper sulfate, as indicated by reduction of average body length and feeding behavior. Reproduction was significantly reduced only at the highest copper dose, though still more pronounced with copper oxide nanoparticles compared to copper sulfate treatment. Furthermore, we investigated the effects of copper oxide nanoparticles and copper sulfate on neurons, cells with known vulnerability to heavy metal toxicity. Degeneration of dopaminergic neurons was observed in up to 10% of the population after copper oxide nanoparticle exposure. Additionally, mutants in the divalent-metal transporters, smf-1 or smf-2, showed increased tolerance to copper exposure, implicating both transporters in copper-induced neurodegeneration. These results highlight the complex nature of CuO nanoparticle toxicity, in which a nanoparticle-specific effect was observed in some traits (average body length, feeding behavior) and a copper ion specific effect was observed for other traits (neurodegeneration, response to stress).

Indexed as

AnimalsBody SizeCaenorhabditis elegansCaenorhabditis elegans ProteinsCation Transport ProteinsCopperDopaminergic NeuronsFeeding BehaviorHumansMutationNanoparticlesNeurodegenerative DiseasesCaenorhabditis elegans ProteinsCation Transport ProteinsCoppercupric oxidesmf-1 protein, C eleganssmf-2 protein, C elegans

Identifiers

PMID27911941
PMCPMC5135131
OpenAlexW2557307285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.